Navigation Links
Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
Date:1/28/2008

HOUSTON(Jan. 28, 2008)Diuretics were associated with reduced heart disease in a drug comparison trial involving 23,077 people with both high blood pressure and the metabolic syndrome, a cluster of risk factors for heart disease, report researchers from The University of Texas School of Public Health and Case Western Reserve University in the Jan. 28 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals. The cardiac benefits connected with diuretics were particularly pronounced in blacks, who have a high incidence of high blood pressure or hypertension.

In hypertensive patients with metabolic syndrome, initial treatment for hypertension should include a diuretic, said senior author Barry Davis, M.D., Ph.D., professor of biostatistics and the director of the Coordinating Center for Clinical Trials at the UT School of Public Health. Diuretics are preferred over other major classes of blood pressure medications to prevent one or more forms of cardiovascular disease.

High blood pressure is one of the risk factors included in the metabolic syndrome along with diabetes or pre-diabetes, excessive belly fat, high triglyceride levels, or low levels of high-density lipoprotein (good cholesterol). It is estimated that about 40 percent of adults age 60 years or older can be classified as having the metabolic syndrome.

According to Davis, the James W. Rockwell Professor of Public Health, diuretics, also known as water pills, offered greater protection against cardiovascular disease including heart failure, and were at least as effective for lowering blood pressure when compared to three other classes of blood pressure medications. The newer medications tend to produce better glucose and cholesterol values but the diuretics tend to generate better patient outcomes, he said.

This is an important study that provides a new insight into diuretic therapy for blood pressure control, particularly in patients with th
'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Diuretics Best for Hypertension and Metabolic Syndrome
2. Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence
3. Health Options, Inc.s BlueMedicare HMO Earns NCQA Excellent Rating
4. Brown named Center of Excellence in Geriatric Medicine and Training
5. Alzheimers Foundation of America Awards Excellence in Dementia Care Status to First Adult Day Center, More Long-Term Care Settings
6. Developing Excellence in Alliance
7. Bridges to Excellence Announces New Implementation Programs for Health Plans and Additions to Board of Directors
8. Hospice Caring, Inc. Earns Seal of Excellence and Elects New Board Member
9. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
10. Sharp HealthCare Receives 2007 Presidential Award for Quality and Performance Excellence
11. Center For Excellence to Fund Analysis of Michigan State Retiree Health Care Reforms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
(Date:12/6/2009)... cell disease, a condition characterized by deformed and ... most common genetic blood disorders affecting millions of ... Americans.(1) Research presented today at the 51st Annual ... intriguing studies on the acute danger that the ... disorder, evaluations of both new and standard treatments ...
(Date:12/6/2009)... Internet Sleep Disorders information and Treatment site ... sleep problems with herbal or natural sleep aids ... ,insomnia remedies for a good cause. The submissions ... Natural Sleep Aids ,Encyclopedia, by YOU, to be ... The site will donate 100% of the proceeds ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2
... WEDNESDAY, Nov. 14 (HealthDay News) -- A protein that may ... to be a biomarker that indicates severe asthma. And it ... according to new research. , Reporting in the Nov. 15 ... Yale University researchers said that people with severe asthma were ...
... 34 years shows parental history, overweight are markers for ... The development of type 2 diabetes in adults can ... that,s followed a group of 814 children and adults ... Center found that parental history of diabetes, as well ...
... Community Hospital of Long Beach (CHLB) is entering to win a ... The hospital that receives the most votes will win the ... taking place NOW through December 31, ... ,Community Hospital of Long Beach, from the drop ...
... prepared testimony of NCPA president Steve Giroux before the ... the counter,availability of certain drugs., "Hello, I am ... and a pharmacist from Middleport, New York., NCPA ... public meeting to,explore the public health benefit of certain ...
... Plastic Surgery Procedures, LAS VEGAS, Nov. 14 ... raised questions about the safety of plastic,surgery. The factors ... concerns over her physician,s lack of board certification and,his ... should,be reassured that Donda West,s tragic outcome is unusual," ...
... donors share in success, Governor Phil Bredesen ... Consortium headquarters, Chili,s Care Center culmination of ... care, MEMPHIS, Tenn., Nov. 14 St. ... celebrated the national,grand opening of the Chili,s Care ...
Other Medicine News:Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Adult Type 2 Diabetes Can Be Predicted in Childhood 2Health News:Community Hospital of Long Beach - Help Us Win an MRI Scanner! 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 3Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 4Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 5Health News:Guide to Minimizing Your Plastic Surgery Risks 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4
(Date:12/4/2009)... Dec. 4 The U.S. Food and ... form as an option for the treatment of schizophrenia ... disorder in adolescents aged 13-17 years old. ,, ... into consideration the increased potential for weight gain and ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Management Health Solutions Inc to Exhibit at HFMA ANI 47574 1Management Health Solutions Inc to Exhibit at HFMA ANI 47574 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 1HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 3HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 4New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 1New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 2
... Provides Real-Time Insight on Viability of Infectious ... Disease Treatment Options -, ... ) today announced that the Texas A&M Health,Science Center Research Foundation ... of more effective therapeutic,treatments for tuberculosis. Research efforts and the purchase ...
... Terumo Heart, Inc. announced,a presentation at the ... "Long Term Circulatory Support with the DuraHeart(TM) ... Eligible for,Transplantation: European Experience" was delivered by ... Terumo Heart, Inc., (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 ...
Other Medicine Technology:Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center 2Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
... The RapidPCP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 25 ng/mL. ... in the point of care location,and ...
The RapidMTD test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of methadone in human urine specimens above a,cut-off level of 300 ng/mL. The a...
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3...
... With membrane parasite ... and cytoplasm as antigen. ... different antigens than the ... possible to use two ...
Medicine Products: